United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure
Sarepta reports positive three-year EMBARK results for ELEVIDYS in ambulatory Duchenne patients
BioArctic partner Eisai secures FDA priority review for Leqembi Iqlik subcutaneous starting dose
Scancell secures FDA clearance for Phase 3 melanoma trial of iSCIB1+
BioCryst Pharmaceuticals acquires Astria Therapeutics
Insilico Medicine's ISM8969 receives US FDA IND approval for Parkinson's Disease
Bausch Health reports RED-C Phase 3 trials failed to meet primary endpoint
ImmunityBio reports promising survival and immune recovery in recurrent glioblastoma study
Sanofi advances amlitelimab toward global filings after phase 3 results in atopic dermatitis
Trevi Therapeutics reports key Phase 2b CORAL trial results for oral nalbuphine ER
Hansa Biopharma receives 2025 SwedenBIO Award
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Actuate Therapeutics advances elraglusib tablet into Phase 1/2 trial for refractory cancers